Stress Reduction Intervention for Racism-Related Stress
Trial Summary
What is the purpose of this trial?
This trial tests if the RiSE program, a short online stress reduction course, can improve well-being and health in African American women at risk for heart or other health issues. The program teaches techniques to manage social stress and promote empowerment. The RiSE program is a short group-based stress reduction program designed to help Black women at risk for heart disease develop effective coping skills for dealing with chronic stress uniquely associated with being a minority.
Will I have to stop taking my current medications?
The trial does not specify whether you need to stop taking your current medications. However, if you are using immune-altering medications like glucocorticoids, you may not be eligible to participate.
What data supports the effectiveness of the treatment HEP, Health Education Program, RiSE, Resilience, Stress, and Ethnicity program for reducing racism-related stress?
Research suggests that interventions aimed at reducing racism can improve health by addressing social factors and empowering individuals, which aligns with the goals of the RiSE program. Additionally, coping strategies like John Henryism have shown positive health effects in managing stress related to racism, indicating potential benefits of similar stress reduction interventions.12345
How is the HEP, RiSE treatment different from other treatments for racism-related stress?
The HEP, RiSE treatment is unique because it is a culturally tailored, group-based program specifically designed to help Black women at risk for cardiovascular disease develop coping skills for chronic stress related to racism, which is not addressed by standard treatments. It focuses on resilience and stress management, making it distinct from other interventions that may not consider the specific stressors faced by minorities.678910
Research Team
Karen Saban, RN, PhD
Principal Investigator
Loyola University Chicago
Eligibility Criteria
This trial is for African American women aged 50-70, post-menopausal, who can read and speak English. They must have risk factors for heart or metabolic disease like high blood pressure, large waist circumference, high cholesterol, or Type 2 diabetes. Excluded are those on immune-altering meds, with recent dental issues, smokers within 3 months, active cancer/infection/substance abuse issues or significant cardiovascular history.Inclusion Criteria
Exclusion Criteria
Trial Timeline
Screening
Participants are screened for eligibility to participate in the trial
Treatment
Participants engage in either the RiSE or Health Education program, meeting online weekly for 8 consecutive weeks
Booster Sessions
Two booster sessions occur one month and two months after completion of the interventions
Follow-up
Participants are monitored for well-being, inflammation, and DNA methylation 6 months after the intervention
Treatment Details
Interventions
- HEP (Behavioral Intervention)
- RiSE (Behavioral Intervention)
Find a Clinic Near You
Who Is Running the Clinical Trial?
Loyola University
Lead Sponsor
Jerome D. Jabbour
Loyola University
Chief Executive Officer since 2018
B.A. in Psychology from Loyola University in Baltimore, Maryland
Dr. Chris Cabell
Loyola University
Chief Medical Officer since 2024
Medical Degree and Masters in Health Sciences from Duke University
Columbia University
Collaborator
Dr. Katrina Armstrong
Columbia University
Chief Executive Officer
MD from Johns Hopkins University, MS in Epidemiology from Harvard School of Public Health
Dr. Katrina Armstrong
Columbia University
Chief Medical Officer
MD from Harvard Medical School